U.S. regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
US recommends ‘pause’ for J&J shots in blow to vaccine drive
WASHINGTON (AP) – The U.S. on Tuesday recommended a "pause" in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccine campaign.
J&J’s 1-dose shot cleared, giving U.S. 3rd COVID-19 vaccine
WASHINGTON (AP) – The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday (Feb. 27) cleared a Johnson & Johnson shot that works with just one dose instead of two.
2nd COVID-19 vaccine set for OK in US with panel endorsement
WASHINGTON (AP) — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
Pfizer vaccine moves closer to getting the OK in the US
WASHINGTON (AP) — U.S. regulators Tuesday released their first scientific evaluation of Pfizer's COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green-light the biggest vaccination effort in the nation's history.
